<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05051917</url>
  </required_header>
  <id_info>
    <org_study_id>22/21</org_study_id>
    <nct_id>NCT05051917</nct_id>
  </id_info>
  <brief_title>The Italian Coronary Artery Aneurysm and Ectasia In Patients With Acute Coronary Syndrome</brief_title>
  <acronym>ITACA</acronym>
  <official_title>ITAlian Coronary Artery Aneurysm and Ectasia Observational Study in Patients With Acute Coronary Syndrome: The ITACA Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondazione GISE Onlus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Federico II University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The ITACA study is a prospective, observational no profit registry enrolling patients with&#xD;
      Acute Coronary Syndrome and angiographic evidence of coronary aneurysms and/or ectasia.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The ITACA study is aimed at evaluating short and long term outcomes in patients with acute&#xD;
      coronary sindrome and angiographic evidence of coronary aneurysm and/or actasia. Data&#xD;
      regarding safety and effectiveness of invasive and pharmacological treatment strategies will&#xD;
      be also collected.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 1, 2021</start_date>
  <completion_date type="Anticipated">September 1, 2026</completion_date>
  <primary_completion_date type="Anticipated">September 1, 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Major adverse cardiac events</measure>
    <time_frame>two years</time_frame>
    <description>A composite endpoint of myocardial infarction, stroke, cardiovascular death, myocardial revascularization and hospitalisation due to cardiovascular events</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <condition>Angiographic Evidence if Coronary Aneurysms</condition>
  <condition>Ectasia</condition>
  <eligibility>
    <study_pop>
      <textblock>
        patients undergoing coronary angiography with diagnosis of ACS and contextual detection of&#xD;
        coronary ectasia or aneurysm in accordance with the definitions specified below. Patients&#xD;
        with coronary pseudoaneurysms are excluded.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Signature of informed consent;&#xD;
&#xD;
          -  Patients aged ≥18 years;&#xD;
&#xD;
          -  diagnosis of ACS (ST-elevation myocardial infarction, non ST-elevation myocardial&#xD;
             infarction, unstable angina), in accordance with the definition provided in the latest&#xD;
             guidelines;&#xD;
&#xD;
          -  diagnosis of ectasia or coronary aneurysm according to the definitions contained in&#xD;
             this protocol, either in the culprit vessel of the SCA than in another vessel.&#xD;
             Coronary pseudoaneurysms are excluded.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  impossibility or unwillingness to provide signed informed consent;&#xD;
&#xD;
          -  contraindications to dual antiplatelet therapy;&#xD;
&#xD;
          -  contraindications to anticoagulant therapy;&#xD;
&#xD;
          -  active bleeding or severe anemia (Hb &lt;6 g / dl);&#xD;
&#xD;
          -  life expectancy &lt;12 months;&#xD;
&#xD;
          -  female patients with potential pregnancy;&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Giuseppe Tarantino</name>
      <address>
        <city>Forlì</city>
        <state>FC</state>
        <zip>47121</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Fabio Tarantino, MD</last_name>
      <phone>+390543735161</phone>
      <email>tarantinofabio@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Simone Grotti, MD</last_name>
      <phone>+390543735161</phone>
      <email>grotti.simone@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Professor Giovanni Esposito</name>
      <address>
        <city>Naples</city>
        <zip>80131</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Esposito, MD</last_name>
      <phone>+390817463075</phone>
      <email>espogiov@unina.it</email>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 15, 2021</study_first_submitted>
  <study_first_submitted_qc>September 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 21, 2021</study_first_posted>
  <last_update_submitted>October 18, 2021</last_update_submitted>
  <last_update_submitted_qc>October 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federico II University</investigator_affiliation>
    <investigator_full_name>Giovanni Esposito</investigator_full_name>
    <investigator_title>Professor of Cardiology</investigator_title>
  </responsible_party>
  <keyword>Aute Coronary Syndrome</keyword>
  <keyword>Coronary Artery Artery</keyword>
  <keyword>Ectasia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm</mesh_term>
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Coronary Aneurysm</mesh_term>
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Dilatation, Pathologic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

